NCT05892159Not yet recruiting
Heart Rate Variability (HRV) Biofeedback to Treat Ulcerative Colitis
Heart Rate Variability Biofeedback in the Treatment of Ulcerative Colitis
Source: ClinicalTrials.gov · Last updated 13 Mar 2026
Brief summary (registry, in English)
This is a prospective interventional study exploring the modifiability of physiological metrics, namely Heart Rate Variability (HRV), using a 5-week standardized HRV biofeedback intervention in subjects with symptomatic ulcerative colitis. Participants will be followed for 17 weeks. The goal is the understand if modifying these markers can impact ulcerative colitis related symptoms.
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 23 (estimated)
- First submitted
- 28 May 2023
- Start date
- 1 Jun 2026
- Primary completion date
- 30 Apr 2027
- Lead sponsor
- Icahn School of Medicine at Mount Sinai
- Diseases
- Ulcerative colitis
- NCT number
- NCT05892159
What you commit to
- Study type: Interventional
- Planned participants: 23
- From 1 Jun 2026 to the primary completion date, 30 Apr 2027
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Individuals who take medications known to alter heart rate variability
Other
- Individuals with pacemakers or other implantable devices
Who the study is looking for
- Adult subjects (18-65 years old)
- Ulcerative colitis with a symptomatic flare (SCCAI ≥3) and without inflammation (FC\<250µg/ml)
Age in the registry: 18 years to 65 years · Sex: All · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.